320 related articles for article (PubMed ID: 31792884)
1. Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.
Miljković F; Bajorath J
J Comput Aided Mol Des; 2020 Jan; 34(1):1-10. PubMed ID: 31792884
[TBL] [Abstract][Full Text] [Related]
2. Systematic computational identification of promiscuity cliff pathways formed by inhibitors of the human kinome.
Miljković F; Vogt M; Bajorath J
J Comput Aided Mol Des; 2019 Jun; 33(6):559-572. PubMed ID: 30915709
[TBL] [Abstract][Full Text] [Related]
3. Activity profile relationships between structurally similar promiscuous compounds.
Hu Y; Bajorath J
Eur J Med Chem; 2013 Nov; 69():393-8. PubMed ID: 24077530
[TBL] [Abstract][Full Text] [Related]
4. Systematic assessment of structure-promiscuity relationships between different types of kinase inhibitors.
Hu H; Bajorath J
Bioorg Med Chem; 2021 Jul; 41():116226. PubMed ID: 34082305
[TBL] [Abstract][Full Text] [Related]
5. Mapping Biological Activities to Different Types of Molecular Scaffolds: Exemplary Application to Protein Kinase Inhibitors.
Dimova D; Bajorath J
Methods Mol Biol; 2018; 1825():327-337. PubMed ID: 30334211
[TBL] [Abstract][Full Text] [Related]
6. Analyzing Promiscuity at the Level of Active Compounds and Targets.
Bajorath J
Mol Inform; 2016 Dec; 35(11-12):583-587. PubMed ID: 27870240
[TBL] [Abstract][Full Text] [Related]
7. Exploring structure-promiscuity relationships using dual-site promiscuity cliffs and corresponding single-site analogs.
Hu H; Bajorath J
Bioorg Med Chem; 2020 Jan; 28(1):115238. PubMed ID: 31818631
[TBL] [Abstract][Full Text] [Related]
8. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Promiscuity Cliffs Using Machine Learning.
Blaschke T; Feldmann C; Bajorath J
Mol Inform; 2021 Jan; 40(1):e2000196. PubMed ID: 32881355
[TBL] [Abstract][Full Text] [Related]
10. Promiscuity analysis of a kinase panel screen with designated p38 alpha inhibitors.
González-Medina M; Miljković F; Haase GS; Drueckes P; Trappe J; Laufer S; Bajorath J
Eur J Med Chem; 2020 Feb; 187():112004. PubMed ID: 31881458
[TBL] [Abstract][Full Text] [Related]
11. Deep Learning Enhancing Kinome-Wide Polypharmacology Profiling: Model Construction and Experiment Validation.
Li X; Li Z; Wu X; Xiong Z; Yang T; Fu Z; Liu X; Tan X; Zhong F; Wan X; Wang D; Ding X; Yang R; Hou H; Li C; Liu H; Chen K; Jiang H; Zheng M
J Med Chem; 2020 Aug; 63(16):8723-8737. PubMed ID: 31364850
[TBL] [Abstract][Full Text] [Related]
12. Systematic Data Analysis and Diagnostic Machine Learning Reveal Differences between Compounds with Single- and Multitarget Activity.
Feldmann C; Yonchev D; Stumpfe D; Bajorath J
Mol Pharm; 2020 Dec; 17(12):4652-4666. PubMed ID: 33151084
[TBL] [Abstract][Full Text] [Related]
13. Mapping of inhibitors and activity data to the human kinome and exploring promiscuity from a ligand and target perspective.
Hu Y; Kunimoto R; Bajorath J
Chem Biol Drug Des; 2017 Jun; 89(6):834-845. PubMed ID: 27933727
[TBL] [Abstract][Full Text] [Related]
14. Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth.
Al-Ali H; Lee DH; Danzi MC; Nassif H; Gautam P; Wennerberg K; Zuercher B; Drewry DH; Lee JK; Lemmon VP; Bixby JL
ACS Chem Biol; 2015 Aug; 10(8):1939-51. PubMed ID: 26056718
[TBL] [Abstract][Full Text] [Related]
15. Identifying Promiscuous Compounds with Activity against Different Target Classes.
Feldmann C; Miljković F; Yonchev D; Bajorath J
Molecules; 2019 Nov; 24(22):. PubMed ID: 31752252
[TBL] [Abstract][Full Text] [Related]
16. Determining the Degree of Promiscuity of Extensively Assayed Compounds.
Jasial S; Hu Y; Bajorath J
PLoS One; 2016; 11(4):e0153873. PubMed ID: 27082988
[TBL] [Abstract][Full Text] [Related]
17. Data structures for compound promiscuity analysis: promiscuity cliffs, pathways and promiscuity hubs formed by inhibitors of the human kinome.
Miljković F; Bajorath J
Future Sci OA; 2019 Jul; 5(7):FSO404. PubMed ID: 31428450
[TBL] [Abstract][Full Text] [Related]
18. Kinome-Wide Profiling Prediction of Small Molecules.
Sorgenfrei FA; Fulle S; Merget B
ChemMedChem; 2018 Mar; 13(6):495-499. PubMed ID: 28544552
[TBL] [Abstract][Full Text] [Related]
19. Web-Based Tools for Polypharmacology Prediction.
Awale M; Reymond JL
Methods Mol Biol; 2019; 1888():255-272. PubMed ID: 30519952
[TBL] [Abstract][Full Text] [Related]
20. Enhancing Molecular Promiscuity Evaluation Through Assay Profiles.
Avram S; Curpan R; Bora A; Neanu C; Halip L
Pharm Res; 2018 Oct; 35(11):240. PubMed ID: 30338400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
